Table 2.

Characteristics of NeuroCOVID patients at the follow-up evaluation.

	n/N	%	95% CI
Disability (mRSa)
Score - median (IQR)	2 (1–3)
0–1	29/60	48.3	35.2–61.6
2–5	31/60	51.7	38.4–64.8
Quality of live (EQ-5D-3Lb)
Not altered	26/51	51.0	36.6–65.2
Altered	25/51	49.0	34.8–63.4
Memory complain (CDS)
Score - median (IQR)	11 (5–18)
Normal (<15)	33/50	66.0	51.2–78.8
Abnormal (≥15)	17/50	34.0	21.2–48.8
Cognitive assessment (MoCA-Blind)
Score - median (IQR)	17 (14–19)
Normal (≥19)	14/45	31.1	18.2–46.6
Abnormal (<19)	31/45	68.9	53.4–81.8
Anxiety - Depression (HADSc)
Anxiety score - median (IQR)	5 (1–9)
Depression score - median (IQR)	2 (1–6)
Not altered	34/50	68.0	53.8–80.5
Altered	16/50	32.0	19.5–46.7
Taste and Smell Survey (TSSd)
Taste score - median (IQR)	0 (0–4)
Smell score - median (IQR)	0 (0–3)
Not altered	28/51	54.9	40.3–68.9
Altered	23/51	45.1	31.1–59.7

Abbreviations: 95% CI: 95% Confidence Interval; IQR: Inter Quartile Range; mRS: modified Rankin Scale; EQ-5D-3L: 3-level version of the EuroQol five-dimension scale; CDS: 35-item version of Cognitive Difficulties Scale; MoCA-Blind: Montreal Cognitive Assessment Blind; HADS: Hospital Anxiety and Depression Scale; TSS: Taste and Smell Survey.

^a0: no symptoms at all; 1: no significant disability despite symptoms; able to carry out all usual duties and activities; 2: slight disability; unable to carry out all previous activities, but able to look after own affairs without assistance; 3: moderate disability; requiring some help, but able to walk without assistance; 4: moderately severe disability; unable to walk without assistance and unable to attend to own bodily needs without assistance; 5: severe disability; bedridden, incontinent and requiring constant nursing care and attention.

^bSignificant alteration when more than one question is at least two points (example: 12211, 21112…).

^cAltered when at least one score, depression or anxiety was > 7.

^dAltered when at least one score, taste or smell was ≥ 1.